Obesity and Left Ventricular Assist Device Driveline Exit Site Infection

被引:83
作者
Raymond, Ashley L. [1 ]
Kfoury, Abdallah G. [1 ]
Bishop, Corey J. [1 ]
Davisj, Erin S. [2 ]
Goebel, Kimberly M. [1 ]
Stoker, Sandi [1 ]
Selzman, Craig H. [2 ]
Clayson, Stephen E. [1 ]
Smith, Hildegard [1 ]
Cowley, Cris G. [1 ]
Alharethi, Rami [1 ]
Budge, Deborah [1 ]
Reid, Bruce B. [1 ]
机构
[1] Intermt Med Ctr, Utah Artificial Heart Program, Murray, UT 84157 USA
[2] Univ Utah, Ventricular Assist Device Program, Salt Lake City, UT USA
关键词
BODY-MASS INDEX; OUTCOMES;
D O I
10.1097/MAT.0b013e3181c879b1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Driveline exit site (IDLES) infection is a persistent problem among the left ventricular assist device (LVAD) patients. This study investigated the relationship between obesity and IDLES infection. Records of LVAD patients at two institutions from January 1999 to January 2009 were queried. Results were analyzed using t tests. Those with LVAD support >= 90 days were included. The body mass index (BMI) of each patient was measured at the time of implant and at the conclusion of LVAD support or currently, if the patient was ongoing. Other data included preimplant age, ejection fraction, blood urea nitrogen, creatinine, diabetes, New York Heart Association class, pulmonary capillary wedge pressure, VO2 max, and inotrope therapy. The 118 patients who qualified for the study were placed in an infection group (n = 36) or in the control group (n = 82). Both groups had similar preimplant characteristics. Variables with differences statistically significant between the groups included duration of LVAD support, indication for support, device type, and BMI. Patients who developed IDLES infections had a significantly higher BMI and continued weight gain over the course of LVAD therapy compared with the control group. Although this association requires further study, implications for clinical practice may include the provision of nutrition and exercise counseling for patients undergoing LVAD therapy, especially if overweight. These results may warrant increased measures to prevent and treat infection in the preimplant and postimplant periods. ASAIO Journal 2010; 56:57-60.
引用
收藏
页码:57 / 60
页数:4
相关论文
共 14 条
[11]   Body mass index and outcome after ventricular assist device placement [J].
Musci, Michele ;
Loforte, Antonio ;
Potapov, Evgenij V. ;
Krabatsch, Thomas ;
Weng, Yuguo ;
Pasic, Miralem ;
Hetzer, Roland .
ANNALS OF THORACIC SURGERY, 2008, 86 (04) :1236-1242
[12]   Improvement in dilated cardiomyopathy after bariatric surgery [J].
Ristow, Bryan ;
Rabkin, John ;
Haeusslein, Ernest .
JOURNAL OF CARDIAC FAILURE, 2008, 14 (03) :198-202
[13]   Long-term use of a left ventricular assist device for end-stage heart failure [J].
Rose, EA ;
Gelijns, AC ;
Moskowitz, AJ ;
Heitjan, DF ;
Stevenson, LW ;
Dembitsky, W ;
Long, JW ;
Ascheim, DD ;
Tierney, AR ;
Levitan, RG ;
Watson, JT ;
Meier, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20) :1435-1443
[14]   Late-onset driveline infections: The Achilles' heel of prolonged left ventricular assist device support [J].
Zierer, Andreas ;
Melby, Spencer J. ;
Voeller, Rochus K. ;
Guthrie, Tracey J. ;
Ewald, Gregory A. ;
Shelton, Kim ;
Pasque, Michael K. ;
Moon, Marc R. ;
Damiano, Ralph J., Jr. ;
Moazami, Nader .
ANNALS OF THORACIC SURGERY, 2007, 84 (02) :515-521